Skip to main content

Table 3 Overview of modeling results

From: FDG PET versus CT radiomics to predict outcome in malignant pleural mesothelioma patients

Performance of model

PFS

OS

FDG PET-model, c-index (95% CI)

Training

Validation

0.67 (0.52–0.82)

0.66 ( 0.57–0.78)

0.72 (0.62–0.84)

0.47 (0.36–0.62)

CT-model, c-index (95% CI)

Training

Validation

0.66 (0.56–0.76)

0.54 (0.44–0.67)

0.71 (0.59–0.80)

0.59 (0.47–0.74)

SUVmax, c-index (95% CI)

Training

Validation

0.55 (0.44–0.60)

0.54 (0.42–0.68)

SUVmean, c-index (95% CI)

Training

Validation

0.52 (0.40–0.66)

0.52 (0.40–0.66)

Volume, c-index (95% CI)

Training

Validation

0.60 (0.49–0.73)

0.57 (0.48–0.67)

0.62 (0.52–0.72)

0.63 (0.50–0.75)

  1. PFS progression-free-survival, OS overall survival